ClinicalTrials.gg
RecruitingNCT05827744Updated Oct 23, 2023

The Relationship Between Thicknesses and Isokinetic Strength of Hip Flexor and Extensor Muscles

An observational study in Amputation, Traumatic, sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital. Recruiting at 1 site in Turkey. Open to male participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-10-23.

Sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 10 months ago, but the record still lists the study as recruiting.
  • Started May 2023; still recruiting 3 years 5 months later.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
27
Ages
18 Years to 65 Years
Sex
Male
01

Study summary

The aim of this study is to investigate the relationship of hip muscle thicknesses measured by ultrasonography with hip flexion and extension strength and clinical parameters in prosthesis users with unilateral traumatic transfemoral amputation.

Read the detailed description

The aim of this study is to investigate the relationship of hip muscle thicknesses measured by ultrasonography with hip flexion and extension strength and clinical parameters in prosthesis users with unilateral traumatic transfemoral amputation.

This study will be useful in understanding whether ultrasonography is an appropriate imaging method in the follow-up of changes in functional strength in the hip girdle in patients with unilateral traumatic transfemoral amputation.

02

Conditions studied

  • Amputation, Traumatic

Browse trials for

Keywords

  • amputation
  • hip flexors
  • hip extensors
03

In context

Amputation, Traumatic

112 studies on the registry are indexed under Amputation, Traumatic; 24 are open to participants now.

This study's planned enrollment of 27 is below the median of 37 across 34 observational studies indexed under Amputation, Traumatic.

Browse Amputation, Traumatic studies →

Lead sponsor

Gaziler Physical Medicine and Rehabilitation Education and Research Hospital is the lead sponsor of 85 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A total of 27 patients with unilateral transfemoral amputation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18-65
  • The time elapsed after amputation > 6 months
  • Using prosthesis for at least 3 months
  • Being able to walk without an assistive device

Exclusion criteria

Exclusion Criteria:

  • Bilateral lower extremity amputation
  • Presence of neurological, cardiovascular, and pulmonary disease that may affect walking performance
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
27 participants (estimated)
Patient registry
No

Interventions

  • OtherIsokinetic evaluations

    Peak torque and total amount of work of hip flexors and extensors will be determined by the Cybex 6000 model computer-aided isokinetic system.

  • OtherUltrasonographic evaluations

    Ultrasonographic evaluations will be performed with a 5-12 MHz linear probe (Logic e portable; GE Healthcare, China). The thicknesses of the hip flexor (psoas major) and extensor (gluteus maximus) muscles will be measured while the patient is in the prone position, in accordance with the literature.

06

What researchers measure

Primary outcomes

  1. 6-minute walking test (6MWT)

    Functional performance will be assessed by 6MWT (in meter). Patients will be instructed to walk quickly, safely, and as much distance as possible over a rectangular path.

    Time frame: through study completion, an average of one month

  2. 10-meter walking test

    The short-distance over-ground gait speed will be assessed using a 10-Meter Walk Test. Participants will be asked to walk at normal pace on a 10-meter walkway.

    Time frame: through study completion, an average of one month

  3. Timed up and go test

    Timed up and go test will be used for quantifying functional mobility balance. Participants will be instructed to sit in a comfortable position on a 45-65 cm high steady chair with a backrest and armrest, with both arms resting on their thighs, and then quickly stand up and move towards and around a fixed cone 3 m away, return, and sit again.

    Time frame: through study completion, an average of one month

07

Study locations

1 of 1 sites recruiting
  • Ankara Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
    Ankara, Turkey
    Recruiting
    • Merve Örücü Atar · Contact
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05827744
Lead sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Responsible party
Yasin Demir (Associate professor, Gaziler Physical Medicine and Rehabilitation Education and Research Hospital) — Principal investigator
First posted
Apr 25, 2023
Start date
May 15, 2023
Primary completion
Dec 15, 2023 (estimated)
Completion
Dec 15, 2023 (estimated)
Last update
Oct 23, 2023

Study contacts

Merve Örücü Atar, MD
Contact
drmerveorucu@hotmail.com
03122912443
Merve Örücü Atar
principal investigator · assistant professor

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion